News from Eli Lilly

Is It Time to Sell Eli Lilly and Pfizer Stocks?

Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip

Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance

Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now

Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

Eli Lilly Expects Zepbound Approval in Japan by Mid-2025, Eyes Weight-Loss Market

The Crackdown on Compounded GLP-1 Meds Has Begun

Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound, caught up in East Coast trade shutdown

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club

US FDA approves Eli Lilly's drug for eczema

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

What Now After Upside Reversal? Six Stocks In Buy Areas

Lilly appoints insider as finance chief amid rising investments to boost capacity

When stocks rally, they tend to run into resistance if they reach a price level that had been resistance before. Here's why this happened with Eli Lilly and Co

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

3 No-Brainer Stocks to Buy in September

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion Club